<ul>
<li>Genenta regained Nasdaq compliance with the $1 minimum bid price requirement, clearing a prior deficiency notice.     *      Nasdaq determined the ADS closing bid price held at or above $1 for 10 straight sessions from June 1 to June 12, 2026.     *      The listing matter is closed, removing the risk of further Nasdaq action tied to the bid-price threshold. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-028831), on June 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</li>
</ul>

GNTA

<p>Genenta Science S.p.A. has regained compliance with Nasdaq's $1 minimum bid price rule. The exchange confirmed that the ADS closing bid price remained at or above $1 for ten consecutive trading sessions from June 1 to June 12, 2026. Consequently, the listing matter is closed, eliminating the risk of further Nasdaq enforcement actions related to this specific deficiency.</p>

Genenta regains Nasdaq compliance with $1 minimum bid price rule